Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
15
Number of overlapping holdings
40.5%
% of IHE's 38 holdings also in FTXH
30.0%
% of FTXH's 51 holdings also in IHE
Overlap by Weight
Sector Drift (IHE minus FTXH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IHE |
Weight in FTXH |
Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 21.2% | 6.9% | 6.9% |
|
BRISTOL-MYERS SQUIBB CO | 5.5% | 8.7% | 5.5% |
|
MERCK & CO. INC. | 4.2% | 6.7% | 4.2% |
|
PFIZER INC | 4.1% | 6.8% | 4.1% |
|
VIATRIS, INC. | 5.3% | 4.1% | 4.1% |
Position Highlights (Non-Overlapping Exposures)
IHE Overweight Relative to FTXH
|
ELI LILLY & CO | 17.2% |
|
JOHNSON & JOHNSON | 14.3% |
|
CATALENT INC | 4.7% |
|
ROYALTY PHARMA PLC CLASS A | 4.0% |
|
INTRA-CELLULAR THERAPIES INC | 2.8% |
|
AXSOME THERAPEUTICS, INC. | 1.5% |
|
CORCEPT THERAPEUTICS INC | 1.3% |
|
VIATRIS, INC. | 1.2% |
|
LIGAND PHARMACEUTICALS-CL B | 0.9% |
|
ELANCO ANIMAL HEALTH, INC. | 0.9% |
IHE Underweight Relative to FTXH
|
ABBVIE INC | -6.9% |
|
GILEAD SCIENCES INC | -4.5% |
|
CARDINAL HEALTH INC | -4.1% |
|
UNITED THERAPEUTICS CORP | -3.7% |
|
BRISTOL-MYERS SQUIBB CO | -3.2% |
|
AMGEN INC | -3.1% |
|
BIOGEN IDEC INC | -2.8% |
|
PFIZER INC | -2.7% |
|
MERCK & CO. INC. | -2.5% |
|
CHARLES RIVER LABORATORIES | -2.4% |